Co-Authors
This is a "connection" page, showing publications co-authored by Jeanne Decara and Anand Patel.
Connection Strength
0.421
-
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms. Int J Hematol. 2026 Jul 21.
Score: 0.062
-
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study. JACC Adv. 2026 Jun; 5(6 Pt 2):102821.
Score: 0.061
-
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms. Blood Adv. 2026 05 26; 10(10):3746-3755.
Score: 0.061
-
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis. Cardiooncology. 2026 Mar 11; 12(1).
Score: 0.060
-
Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms. Blood Adv. 2026 Mar 10; 10(5):1603-1613.
Score: 0.060
-
Ruxolitinib and heart failure outcomes among patients with myelofibrosis. Leuk Lymphoma. 2026 May; 67(6):1335-1342.
Score: 0.060
-
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Aug; 7(5):538-553.
Score: 0.057